Patent · US Active

Method for production of recombinant human alpha-galactosidase A

US9617529B2 · kind B2 · utility

1Cited by
1References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 24, 2013
Grant dateApr 11, 2017
Priority date
Expiry dateOct 4, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N9/2465
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Disclosed is a method for production of recombinant human alpha-galactosidase A (rh alpha-Gal A) in a large scale, with a high purity. The method comprises the steps of (a) culturing rh alpha-Gal A-producing mammalian cells in a serum-free medium, (b) collecting culture supernatant, (c) subjecting the culture supernatant to anion-exchange column chromatography, (d) to hydrophobic column chromatography, (e) to a column chromatography employing as solid phase a material having affinity for phosphate group, (f) to cation-exchange column chromatography, and (g) to gel filtration column chromatography, in the order.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.